These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 22882693)

  • 61. Clinical sources and prevalence of resistance to antimicrobials of Klebsiella pneumoniae strains in Trinidad.
    Orrett FA
    Saudi Med J; 2005 Nov; 26(11):1766-70. PubMed ID: 16311663
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Epidemiology of carbapenem-resistant
    Wang Y; Lei H; Zhang Y; Yang Q; Wang Y; Wang J; Xu C; Yu J; Zhou L; Kang X; Cui L
    Antimicrob Resist Infect Control; 2018; 7():66. PubMed ID: 29942492
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Carbapenem-Resistant Klebsiella pneumoniae influences the outcome of early infections in liver transplant recipients.
    Barchiesi F; Montalti R; Castelli P; Nicolini D; Staffolani S; Mocchegiani F; Fiorentini A; Manso E; Vivarelli M
    BMC Infect Dis; 2016 Oct; 16(1):538. PubMed ID: 27716164
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Extended spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae isolated in a rural hospital.
    Basak S; Mallick SK; Bose S
    J Indian Med Assoc; 2009 Dec; 107(12):855-8. PubMed ID: 20509468
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes.
    Lautenbach E; Patel JB; Bilker WB; Edelstein PH; Fishman NO
    Clin Infect Dis; 2001 Apr; 32(8):1162-71. PubMed ID: 11283805
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Extended spectrum β-lactamase-producing Enterobacteriaceae infection in heart and lung transplant recipients and in mechanical circulatory support recipients.
    Bui KT; Mehta S; Khuu TH; Ross D; Carlson M; Leibowitz MR; Schaenman JM; Saggar R; Lynch JP; Ardehali A; Kubak BM
    Transplantation; 2014 Mar; 97(5):590-4. PubMed ID: 24162251
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Collateral damage of flomoxef therapy: in vivo development of porin deficiency and acquisition of blaDHA-1 leading to ertapenem resistance in a clinical isolate of Klebsiella pneumoniae producing CTX-M-3 and SHV-5 beta-lactamases.
    Lee CH; Chu C; Liu JW; Chen YS; Chiu CJ; Su LH
    J Antimicrob Chemother; 2007 Aug; 60(2):410-3. PubMed ID: 17576696
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Risk factors for increasing multidrug resistance among extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species.
    Hyle EP; Lipworth AD; Zaoutis TE; Nachamkin I; Fishman NO; Bilker WB; Mao X; Lautenbach E
    Clin Infect Dis; 2005 May; 40(9):1317-24. PubMed ID: 15825035
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Strains of Klebsiella pneumoniae producing extended spectrum beta-lactamases, isolated from organ recipients.
    de Walthoffen SW; Mlynarczyk A; Sawicka-Grzelak A; Durlik M; Paczek L; Chmura A; Ciszek M; Chabros L; Baczkowska T; Mlynarczyk G
    Transplant Proc; 2011 Oct; 43(8):3128-9. PubMed ID: 21996244
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Extended-spectrum beta-lactamase-producing bacterial infections in adult solid organ transplant recipients.
    Winters HA; Parbhoo RK; Schafer JJ; Goff DA
    Ann Pharmacother; 2011 Mar; 45(3):309-16. PubMed ID: 21386016
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Carbapenem-resistant Klebsiella pneumoniae in post-acute-care facilities in Israel.
    Ben-David D; Masarwa S; Navon-Venezia S; Mishali H; Fridental I; Rubinovitch B; Smollan G; Carmeli Y; Schwaber MJ;
    Infect Control Hosp Epidemiol; 2011 Sep; 32(9):845-53. PubMed ID: 21828964
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Control of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a children's hospital by changing antimicrobial agent usage policy.
    Lee J; Pai H; Kim YK; Kim NH; Eun BW; Kang HJ; Park KH; Choi EH; Shin HY; Kim EC; Lee HJ; Ahn HS
    J Antimicrob Chemother; 2007 Sep; 60(3):629-37. PubMed ID: 17599919
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Attributable mortality of carbapenem-resistant Klebsiella pneumoniae infections in a prospective matched cohort study in Italy, 2012-2013.
    Hoxha A; Kärki T; Giambi C; Montano C; Sisto A; Bella A; D'Ancona F;
    J Hosp Infect; 2016 Jan; 92(1):61-6. PubMed ID: 26319590
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality.
    Schwaber MJ; Klarfeld-Lidji S; Navon-Venezia S; Schwartz D; Leavitt A; Carmeli Y
    Antimicrob Agents Chemother; 2008 Mar; 52(3):1028-33. PubMed ID: 18086836
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Clinical Outcomes and Risk Factors for Death following Carbapenem-Resistant Klebsiella pneumoniae Infection in Solid Organ Transplant Recipients.
    Lu J; Zhang A; Han L; Guo Z; Cui W; Jiang Y; Meng H
    Microbiol Spectr; 2023 Feb; 11(1):e0475522. PubMed ID: 36515527
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Gastrointestinal colonization by KPC-producing Klebsiella pneumoniae following hospital discharge: duration of carriage and risk factors for persistent carriage.
    Feldman N; Adler A; Molshatzki N; Navon-Venezia S; Khabra E; Cohen D; Carmeli Y
    Clin Microbiol Infect; 2013 Apr; 19(4):E190-6. PubMed ID: 23331385
    [TBL] [Abstract][Full Text] [Related]  

  • 77.
    Li D; Huang X; Rao H; Yu H; Long S; Li Y; Zhang J
    Front Cell Infect Microbiol; 2023; 13():1157010. PubMed ID: 37153146
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Risk of Bronchial Dehiscence in Lung Transplant Recipients With Carbapenemase-producing Klebsiella.
    Suh JW; Lee JG; Jeong SJ; Park MS; Kim SY; Paik HC
    Ann Thorac Surg; 2020 Jul; 110(1):265-271. PubMed ID: 32151582
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Spectrum of excess mortality due to carbapenem-resistant Klebsiella pneumoniae infections.
    Hauck C; Cober E; Richter SS; Perez F; Salata RA; Kalayjian RC; Watkins RR; Scalera NM; Doi Y; Kaye KS; Evans S; Fowler VG; Bonomo RA; van Duin D;
    Clin Microbiol Infect; 2016 Jun; 22(6):513-9. PubMed ID: 26850824
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Institutional control measures to curtail the epidemic spread of carbapenem-resistant Klebsiella pneumoniae: a 4-year perspective.
    Cohen MJ; Block C; Levin PD; Schwartz C; Gross I; Weiss Y; Moses AE; Benenson S
    Infect Control Hosp Epidemiol; 2011 Jul; 32(7):673-8. PubMed ID: 21666398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.